Reveal SNP Microarray and Abbreviated Chromosome Analysis (Amniotic Fluid)

CPT 81229; 88235; 88261; 88280
Synonyms
  • Amniotic Fluid Chromosome Five-cell Count Plus Microarray

Test Details

Use

The test allows prenatal detection of chromosomal aneuploidy, and is used to rule out tetraploidy and rearrangements not detected by array, such as balanced translocations and inversions. It also helps to clarify array abnormalities to determine if a structural rearrangement, marker, or isochromosome is present. Array can only provide copy number imbalances and cannot determine structure of an abnormality. The SNP assay will detect chromosomal imbalances that could be associated with developmental delay/congenital anomalies. It provides detection of possible uniparental disomy of any chromosome, the percent and location of homozygosity, including the degree of identity by descent.

Special Instructions

A completed Clinical Questionnaire for SNP Microarray should accompany specimens. Call 800-345-4363 to request the appropriate form, or photocopy the form from the Genetics Appendix. Concurrent maternal contamination (MCC) studies (Maternal Cell Contamination [511402]) are  recommended. If prior NIPT studies have been performed, include copy of the report. If specimens from a twin pregnancy are submitted by request it can be reported if these are DZ or MZ twins. Gender by ultrasound is required. 

If the specimen does not meet minimum DNA quality and quantity requirements, array testing will be performed on cultured material. If cultures are needed and performed by Labcorp, additional days will be required to complete testing. A delay notification will be sent to the client if cultures are necessary.

Test Includes

DNA extraction; interpretation; limited five-cell amniotic sample chromosome analysis (two analyses, one karyotype)

Limitations

This SNP assay does not detect balanced rearrangements, low-level mosaicism (<10%), marker chromosomes that only contain heterochromatin or tetraploidy.

This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.

Methodology

Five-cell G-Band Chromosome analysis. SNP microarray analysis is performed using the Cytoscan® HD Accel platform, which uses more than 743,130 SNP probes and 2,029,441 NPCN probes with a median spacing of 0.818 kb.

Related Documents

For more information, please view the literature below.

 

Clinical Questionnaire for Prenatal SNP Microarray

Specimen Requirements

Information on collection, storage, and volume

Specimen

Amniotic fluid

Volume

25 mL amniotic fluid for concurrent array and chromosome analysis

Minimum Volume

12 mL amniotic fluid (minimum volume may delay results; cells would need to be cultured for microarray analysis)

Container

Sterile plastic conical tube

Storage Instructions

Maintain specimen at room temperature.

Causes for Rejection

Upon receipt, suitability of specimen will be determined by the Cytogenetics laboratory.

Collection

Discard first 2 mL of fluid aspirated to avoid maternal cell contamination. Specimen is collected in a 20 mL sterile syringe and transferred aseptically to sterile tubes to be transported to Labcorp. Test request form is completed and accompanies specimen and miscellaneous slip to the laboratory. Rubber stopper and/or frozen specimen cannot be processed.